Implementation and monitoring

Rigorous implementation and monitoring are essential to ensure that a paediatric trial is conducted in accordance with the protocol, good clinical practice standards and applicable regulatory requirements and that the safety of participants is protected throughout the trial.

Implementation and monitoring strategies

Clinical trial monitoring – the act of overseeing the progress of a trial and ensuring that it is conducted, recorded and reported in accordance with the protocol, standard operating procedures, good clinical practice and applicable regulatory requirements – is a core component of clinical trial quality management. A risk-based monitoring approach, as recommended by ICH E6(R3) (Good Clinical Practice Revised Guideline), focuses monitoring resources on the processes and data items with the greatest potential impact on participant safety and data integrity.

For paediatric trials, additional monitoring focus areas include:

  • consent and assent process
  • compliance with blood volume limits
  • adverse event identification and reporting
  • age-appropriate assessment procedures.

For details on post-marketing surveillance and pharmacovigilance, see Module 1.

Key resources